Fig. 2From: Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinomaProgression-free survival (PFS) curves (months) after 1:1 propensity score matching (matching predictors included the ages, Lauren classification, T and N categories). A sAFP-N versus sAFP-H (P = 0.048). B GAPEP versus nGAPEP (P = 0.035)Back to article page